Bottom line
IHI vs IYH: the short answer
IHI (iShares U.S. Medical Devices ETF) and IYH (iShares U.S. Healthcare ETF) are quite different portfolios: only about 16% of their top holdings (by weight) are shared.
But IYH is far broader, holding 103 positions to 50 for IHI, so beyond the top names it adds exposure IHI doesn't have.
Both charge the same expense ratio (0.37%).
Over five years, IYH returned +7.0% a year vs +3.1% for IHI.
Updated Nov 19, 2026
IHI vs IYH side by side
| IHI | IYH | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | iShares | iShares |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.37% | 0.37% |
| Annual cost per $10k | $37 | $37 |
| 10-yr cost on $10k (prospectus) | $468 | $468 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +6.9% | +13.1% |
| 5-yr return (annualized) | +3.1% | +7.0% |
| 10-yr return (annualized) | +12.2% | +9.4% |
| Best quarter | +17.6% | +15.3% |
| Worst quarter | −17.2% | −12.7% |
| Net assets (fund) | $3.0B | $3.6B |
| Number of holdings | 50 | 103 |
| Portfolio turnover | 12% | 3% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | IHI | IYH | Difference |
|---|---|---|---|
| 2025 | +6.9% | +13.1% | −6.3% |
| 2024 | +8.6% | +3.1% | +5.5% |
| 2023 | +3.2% | +2.1% | +1.2% |
| 2022 | −19.7% | −4.4% | −15.3% |
| 2021 | +21.0% | +23.4% | −2.4% |
| 2020 | +24.2% | +15.5% | +8.7% |
| 2019 | +32.7% | +20.8% | +11.9% |
| 2018 | +15.5% | +5.9% | +9.6% |
| 2017 | +30.9% | +22.3% | +8.6% |
| 2016 | +9.2% | −2.8% | +12.0% |
Source: Fund prospectus bar charts
Holdings overlap
9 of IHI's top 25 holdings also appear in IYH's top 25.
| Holding | IHI | IYH |
|---|---|---|
| Abbott Laboratories | 16.93% | 3.02% |
| Intuitive Surgical, Inc. | 15.09% | 2.05% |
| Stryker Corporation | 11.64% | 1.86% |
| Edwards Lifesciences Corporation | 4.75% | 0.81% |
| Becton, Dickinson And Company | 4.63% | 0.78% |
| Medtronic Public Limited Company | 4.40% | 1.80% |
| Idexx Laboratories, Inc. | 4.27% | 0.73% |
| Boston Scientific Corporation | 3.99% | 1.14% |
| BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares | 2.15% | 0.80% |
Source: SEC Form N-PORT
IHI top 10
- Abbott Laboratories — 16.93%
- Intuitive Surgical, Inc. — 15.09%
- Stryker Corporation — 11.64%
- Edwards Lifesciences Corporation — 4.75%
- Becton, Dickinson And Company — 4.63%
- Ge Healthcare Technologies Inc. — 4.51%
- Medtronic Public Limited Company — 4.40%
- Resmed Inc. — 4.38%
- Idexx Laboratories, Inc. — 4.27%
- Dexcom, Inc. — 4.02%
IYH top 10
- Eli Lilly And Company — 15.11%
- Johnson & Johnson — 10.17%
- Abbvie Inc. — 7.32%
- Unitedhealth Group Incorporated — 6.16%
- Merck & Co., Inc. — 5.31%
- Thermo Fisher Scientific Incorporated — 3.52%
- Amgen Inc. — 3.42%
- Abbott Laboratories — 3.02%
- Gilead Sciences, Inc. — 2.66%
- Pfizer Inc. — 2.35%
FAQ
What is the difference between IHI and IYH?
Which is cheaper, IHI or IYH?
Should I own both IHI and IYH?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.